Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
70
HCA Quote, Financials, Valuation and Earnings
Last price:
$483.47
Seasonality move
:
8.71%
Day range:
$465.01 - $478.27
52-week range:
$295.00 - $520.00
Dividend yield:
0.6%
P/E ratio:
18.47x
P/S ratio:
1.58x
P/B ratio:
--
Volume:
1.2M
Avg. volume:
1.3M
1-year change:
61.05%
Market cap:
$109B
Revenue:
$70.6B
EPS (TTM):
$25.88
Analysts' Opinion
-
Consensus RatingHCA Healthcare, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 8 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $481.95, HCA Healthcare, Inc. has an estimated upside of 0.86% from its current price of $477.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $368.00 representing 100% downside risk from its current price of $477.83.
Fair Value
-
According to the consensus of 22 analysts, HCA Healthcare, Inc. has 0.86% upside to fair value with a price target of $481.95 per share.
HCA vs. S&P 500
-
Over the past 5 trading days, HCA Healthcare, Inc. has underperformed the S&P 500 by -0.67% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
HCA Healthcare, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HCA Healthcare, Inc. has grown year-over-year revenues for 12 quarters straight. In the most recent quarter HCA Healthcare, Inc. reported revenues of $19.2B.
Earnings Growth
-
HCA Healthcare, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter HCA Healthcare, Inc. reported earnings per share of $6.96.
Enterprise value:
157.5B
EV / Invested capital:
--
Price / LTM sales:
1.58x
EV / EBIT:
13.54x
EV / Revenue:
2.12x
PEG ratio (5yr expected):
1.14x
EV / Free cash flow:
19.45x
Price / Operating cash flow:
14.50x
Enterprise value / EBITDA:
10.43x
Gross Profit (TTM):
$11.6B
Return On Assets:
12.26%
Net Income Margin (TTM):
9.82%
Return On Equity:
3428.29%
Return On Invested Capital:
16.11%
Operating Margin:
15.47%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $63.2B | $69.6B | $74.4B | $17.5B | $19.2B | |
| Gross Profit | $9.2B | $10.5B | $11.6B | $2.4B | $3B | |
| Operating Income | $9.2B | $10.5B | $11.6B | $2.4B | $3B | |
| EBITDA | $12.3B | $13.7B | $15.1B | $3.3B | $3.9B | |
| Diluted EPS | $20.34 | $22.28 | $25.88 | $4.89 | $6.96 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $13.2B | $13.5B | $14.3B | $16.7B | $15.3B | |
| Total Assets | $49.6B | $51.5B | $54.6B | $59.5B | $59.7B | |
| Current Liabilities | $9.6B | $9.8B | $12.4B | $14.9B | $17.9B | |
| Total Liabilities | $47.7B | $52.3B | $54.2B | $58.7B | $61.9B | |
| Total Equity | $1.8B | -$778M | $357M | $786M | -$2.2B | |
| Total Debt | $34B | $39.5B | $41.1B | $44.9B | $46.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $9.3B | $10.6B | $12.8B | $3.5B | $4.4B | |
| Cash From Investing | -$4.5B | -$5.2B | -$5B | -$1.4B | -$1.4B | |
| Cash From Financing | -$4.9B | -$3.5B | -$9.7B | -$110M | -$3B | |
| Free Cash Flow | $4.4B | $5.9B | $8.1B | $2.3B | $3.1B | |
HCA
Sector
Market Cap
$109B
$28.1M
Price % of 52-Week High
91.89%
50.9%
Dividend Yield
0.6%
0%
Shareholder Yield
9.33%
-1.55%
1-Year Price Total Return
61.05%
-19.36%
Beta (5-Year)
1.362
0.498
Dividend yield:
0.6%
Annualized payout:
$2.64
Payout ratio:
10.35%
Growth streak:
4 years
Technicals
8-day SMA
Buy
Level
$473.45
200-day SMA
Buy
Level
$402.55
Bollinger Bands (100)
Buy
Level
409.88 - 479.7
Chaikin Money Flow
Buy
Level
334.8M
20-day SMA
Buy
Level
$475.70
Relative Strength Index (RSI14)
Buy
Level
51.80
ADX Line
Sell
Level
17.97
Williams %R
Sell
Level
-15.2994
50-day SMA
Buy
Level
$476.94
MACD (12, 26)
Sell
Level
-1.44
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
487.1M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.5099)
Sell
CA Score
(Annual)
Level (-1.6291)
Buy
Beneish M-Score
(Annual)
Level (-2.6356)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.3143)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
Stock Forecast FAQ
In the current month, HCA has received 13 Buy ratings 8 Hold ratings, and 1 Sell ratings. The HCA average analyst price target in the past 3 months is $481.95.
-
Where Will HCA Healthcare, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that HCA Healthcare, Inc. share price will rise to $481.95 per share over the next 12 months.
-
What Do Analysts Say About HCA Healthcare, Inc.?
Analysts are divided on their view about HCA Healthcare, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HCA Healthcare, Inc. is a Sell and believe this share price will drop from its current level to $368.00.
-
What Is HCA Healthcare, Inc.'s Price Target?
The price target for HCA Healthcare, Inc. over the next 1-year time period is forecast to be $481.95 according to 22 Wall Street analysts, 13 of them rate the stock a Buy, 1 rates the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is HCA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HCA Healthcare, Inc. is a Buy. 13 of 22 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HCA?
You can purchase shares of HCA Healthcare, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HCA Healthcare, Inc. shares.
-
What Is The HCA Healthcare, Inc. Share Price Today?
HCA Healthcare, Inc. was last trading at $483.47 per share. This represents the most recent stock quote for HCA Healthcare, Inc.. Yesterday, HCA Healthcare, Inc. closed at $477.83 per share.
-
How To Buy HCA Healthcare, Inc. Stock Online?
In order to purchase HCA Healthcare, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HCA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HCA
Sector
P/E ratio
18.47x
24.09x
PEG ratio
1.14x
-0.01x
P/B ratio
--
1.83x
Price / LTM sales
1.58x
1.59x
Growth Metrics
HCA
Sector
Revenue growth
9.57%
4.68%
Earnings growth
42.37%
10.88%
Revenue (5-year growth)
6.58%
6.45%
Earnings forecast
$7.47
-$0.18
Profitability
HCA
Sector
Profitability FY 2024
$10.5B
$3.6M
Return on invested capital
16.11%
-31.87%
Return on assets
12.26%
-28.18%
Return on equity
3428.29%
-37.89%
Earnings Date
Last Earnings Date
Oct
24
Next Earnings Date
Jan
27
Estimated Next Earnings Date
Jan
23
Balance Sheet
HCA
Sector
Total cash
$1.1B
$26.2M
Short term investments
--
$25.7M
Total assets
$59.5B
$76.7M
Long term debt
$46.3B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
RGC alert for Jan 6
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Buy
73
INOD alert for Jan 6
Innodata, Inc. [INOD] is up 4.84% over the past day.
Buy
65
AVAV alert for Jan 6
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
